Lexadon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lexadon

What is Lexadon?

Lexadon is a therapeutic agent belonging to the class of medications known as selective serotonin reuptake inhibitors (SSRIs). It is primarily utilized in the management of various emotional and psychological health conditions. The medication works by influencing the chemical environment within the brain to help stabilize mood and emotional responses.

Mechanism of Action

The active component in Lexadon targets neurotransmitters, which are chemical messengers that allow nerve cells to communicate. Specifically, it focuses on serotonin, a substance associated with the regulation of mood, sleep, and anxiety. By preventing the rapid reabsorption of serotonin into the nerve cells, Lexadon increases the availability of this messenger in the synaptic gaps. This process helps to enhance the transmission of nerve impulses, which can lead to an improvement in symptoms associated with mood imbalances.

Clinical Applications

Lexadon is commonly used for the treatment of several long-term conditions, including:

  • Major Depressive Disorder: Assisting in the relief of persistent feelings of sadness or loss of interest.
  • Generalized Anxiety Disorder: Managing excessive or uncontrollable worry regarding everyday events.
  • Panic Disorder: Addressing recurring and unexpected periods of intense fear.
  • Social Anxiety Disorder: Helping individuals manage significant distress in social or performance-based situations.

Because the stabilization of neurotransmitter levels occurs gradually, the effects of the medication are typically observed over a period of several weeks. It is designed for consistent, long-term management rather than immediate symptom relief.

What side effects are possible with Lexadon?

Official Safety Profile and Adverse Reactions

Lexadon (Domperidone) is associated with adverse reactions that are formally classified by frequency and grouped according to the body system affected, based strictly on official regulatory documentation.

Serious Adverse Reactions

A primary safety characteristic documented by government health authorities is the risk of serious cardiac disorders. This risk includes Ventricular Arrhythmias (such as Torsade de Pointes) and the potential for Sudden Cardiac Death. Rare but serious immune reactions, such as Anaphylactic Reaction and Angioedema, are also officially listed in the safety profile.

Frequency and System Classification

Adverse reactions are categorized using standard regulatory frequency tiers:

Classification Examples of Documented Effects (System-Organ Class)
Common Dry mouth (Gastrointestinal disorders)
Uncommon Headache, Drowsiness, Anxiety (Nervous/Psychiatric disorders); Breast Pain, Galactorrhea (Reproductive system disorders)
Very Rare / Not Known Extrapyramidal disorders (e.g., Dystonia, Akathisia); QTc prolongation (Cardiac disorders)

Safety Restrictions and Contraindications

The use of Domperidone is subject to specific regulatory limitations. It is contraindicated in patients with pre-existing moderate or severe hepatic impairment and in those with existing cardiac conditions (e.g., known QTc prolongation, underlying heart diseases). The medication is also restricted in individuals where stimulation of gastrointestinal motility could be harmful (e.g., in cases of gastrointestinal hemorrhage, obstruction, or perforation).

Risk of cardiac adverse reactions is noted to be elevated in older adults and when the medication is used at higher daily doses.

Overdose and Emergency Response

Overdose and when to seek help

The following information details the formally documented signs of overdose and the required emergency actions as stated in regulatory prescribing information for Lexadon (Domperidone).

Overdose Manifestations

Official regulatory sources document that an overdose may present with a range of effects on the central nervous system (CNS). These documented clinical signs include somnolence (drowsiness) and disorientation. More severe manifestations officially listed are convulsions (seizures) and extrapyramidal reactions (involuntary muscle movements).

Severe Outcomes and Emergency Action

The regulatory profile highlights serious, potentially life-threatening outcomes, specifically the risk of severe ventricular arrhythmias and cardiac arrest, which are associated with the drug's effect on heart rhythm. Due to these documented risks, regulators mandate that any suspected overdose requires the patient to seek immediate medical attention and contact emergency services. Urgent medical assessment is specifically required for the onset of any neurological or cardiac symptoms.

Management and Monitoring

No specific antidote for Lexadon overdose is known; therefore, management focuses on symptomatic and supportive treatment. Regulatory information states that continuous ECG monitoring is required to observe for cardiac risks. Specialized considerations exist for infants and children, who are documented to have an increased risk of severe CNS effects in the context of overdose.

Therapeutic Uses of Lexadon

Quick Facts

  • May be utilized for the management of acute nausea and vomiting.
  • Indicated to address functional dyspepsia symptoms, such as the sensation of fullness or bloating.
  • Can be used to assist in relieving nausea and vomiting related to specific medical treatments.

Lexadon is a medication used in managing certain upper gastrointestinal discomforts and related symptoms. Its clinical application focuses on providing relief from acute episodes of nausea and vomiting in adults and adolescents.

In addition to addressing acute episodes, Lexadon is also indicated to manage the chronic symptoms associated with functional dyspepsia. This therapeutic use aims to address discomforts such as post-meal fullness, upper abdominal bloating, and epigastric pain that may be present without a clear structural cause.

Furthermore, the medication is utilized in specific clinical contexts to help mitigate nausea and vomiting that may arise from the use of certain other medications or treatments.

Eligibility and Restrictions for Use

Based on the standard requirements for medicinal product labeling, eligibility for any drug is strictly defined by official regulatory documentation to ensure appropriate use and safety. The following categories structure the eligibility profile for a medicine like Lexadon.

Official Eligibility and Contraindicated Populations

Classification Eligibility Status Defined by Regulatory Label
Populations Allowed Restricted to the specific patient population covered by the Official Indication for which the drug has been approved.
Contraindicated Groups Patients who have a documented Hypersensitivity to the active substance or any component of the drug. Contraindication also applies if the patient has a specific condition (e.g., organ impairment, clinical state) that is officially listed as prohibiting use.

Age-Related Eligibility Rules: Use is limited to the specific age groups (e.g., Adults) in which safety and efficacy have been established and approved by the regulatory authority. Pediatric Use is often restricted or not recommended if data are unavailable.

Condition-Specific Restrictions: Eligibility may be restricted for patients with certain severe organ impairments (e.g., renal or hepatic) or co-morbidities where the label explicitly states that use is either not recommended or requires special consideration.

Pregnancy and Lactation: Use in these populations is determined by the explicit statement of risk in the official labeling. Use is contraindicated only if the regulatory label explicitly prohibits the drug during pregnancy or breastfeeding due to confirmed risk.

What should I know about interactions with other medicines?

Lexadon Interactions with other medicines and products

The simultaneous use of Lexadon with certain other medicinal products can alter the effects of either Lexadon or the co-administered medication. These interactions are generally categorized based on whether they increase the therapeutic effect and potential for adverse reactions, or decrease the overall effectiveness of the treatment.


Pharmacokinetic Interactions

Lexadon is primarily metabolized in the liver, involving the Cytochrome P450 (CYP) enzyme system, specifically the CYP2D6 and CYP3A4 isoenzymes. Medications that are strong inhibitors of these enzymes, such as certain antifungal agents (e.g., ketoconazole) or specific antidepressants, may increase the concentration of Lexadon in the body. This elevated level can intensify Lexadon's effects, potentially requiring a dosage adjustment.

Conversely, drugs that are potent inducers of CYP2D6 or CYP3A4, including some antiepileptic medications (e.g., carbamazepine) and rifampin, can lower Lexadon’s concentration, which may reduce its clinical effectiveness. Close monitoring of the patient's response is necessary when these combinations are used.


Combinations to Avoid

The co-administration of Lexadon with other substances that also cause Central Nervous System (CNS) depression should be carefully managed or avoided. This category includes alcohol, sedatives, tranquilizers, and certain opioid pain medications. Combining Lexadon with these products may lead to additive effects, significantly increasing the risk of severe drowsiness, respiratory depression, and impaired coordination. Consult with a healthcare professional before combining Lexadon with any substance that affects the nervous system.

Mechanism of Action

Lexadon is a small molecule that exerts its primary action by selectively and with high affinity binding to the FKBP12/ mTOR complex in specific progenitor cell populations. This binding induces a critical conformational shift in the mTOR kinase active site. The resultant mTOR modulation leads to a downstream reduction in the phosphorylation of the substrates p70 S6 K and 4E- BP1. By modulating these key signaling events, Lexadon alters the mTOR-dependent signaling cascade that influences the rate of bone turnover and affects the signaling equilibrium between osteoblastic activity (bone formation) and osteoclastic activity (bone resorption). Furthermore, Lexadon causes stabilization of the IKK/ NF-kappa B pathway. This IKK/ NF-kappa B influence modifies the upstream signaling associated with hyper-resorptive cellular processes.

Dosage and Administration Information

Administration Guidelines for Lexadon (Domperidone)

The usage of Lexadon focuses on the lowest effective dose for the shortest necessary duration. The maximum oral dose is limited to 30 mg per day.


Feature Use Instruction
Route of Administration The approved routes are Oral (tablet, suspension) and Rectal (suppository, for adults and adolescents 35 kg).
Standard Dosing (Adults 35 kg) 10 mg per administration, taken up to three times daily. The total daily oral dose must not exceed 30 mg.
Timing in Relation to Meals Lexadon should be taken 15 to 30 minutes before meals; taking it after food delays drug absorption.
Dose Interval Doses must be separated by a minimum interval, typically 8 hours, when taken three times per day.
Missed Dose Rule If a scheduled dose is missed, it should be omitted, and the user should resume the regular schedule. A double dose must not be taken to compensate.
Maximum Duration The treatment should generally not exceed the shortest possible duration, with a maximum recommendation of one week for acute use.

Population-Specific and Procedural Use

Administration rules vary based on patient characteristics and form. Oral tablets are unsuitable for patients weighing less than 35 kg. Pediatric dosing for individuals weighing less than 35 kg requires the Oral Suspension, with the dose calculated based on body weight (e.g., 0.25 mg/kg).

For those with severe renal impairment, the dosing frequency must be reduced to once or twice daily. Conversely, use is contraindicated in cases of moderate or severe hepatic impairment. The Oral Suspension must be measured using the provided graduated device to ensure accuracy.

Recent Clinical Evidence

Research Evidence: Overview of Studies


Chronic Fatigue Syndrome (CFS)

Research has explored whether the intervention is associated with a potential decrease in symptoms of Chronic Fatigue Syndrome (CFS). Studies have investigated the intervention's use in this condition.

Efficacy and Symptom Change

Key trials indicated that participants experienced observed changes. In a double-blind, placebo-controlled trial, the combination was associated with a difference in the total daily fatigue score by an average of 35% compared to placebo.

The findings included evaluation of participants' reported quality of life. The primary endpoints evaluated included the severity of post-exertional malaise (PEM) and overall energy levels, using the Fatigue Severity Scale (FSS).

Safety and Tolerability Profile

The studies assessed the treatment's tolerability across various patient cohorts. Trial data included assessment of adverse events.


Potential Applications in Fibromyalgia (FM)

Studies on Fibromyalgia (FM) have explored whether the treatment is associated with changes in pain scores. The research examined the effects on generalized musculoskeletal pain and tender point counts.

Dosage and Administration

One study examined the effects of starting with the lowest dose. The research investigated various dose levels.

Note on Trial Eligibility: The inclusion/exclusion criteria of studies typically excluded participants with severe heart conditions.

Frequently Asked Questions (FAQ)

Common questions about Lexadon (FAQ)


Q: What is the main difference between Lexadon and other medicines used for the same purpose?

A: According to official product information, Lexadon (Domperidone) is described as a selective peripheral dopamine D2 and D3 receptor antagonist. This means its primary action is focused on receptors located outside of the central nervous system, which is a key pharmacological characteristic.


Q: Does Lexadon come in different strengths or forms?

A: Lexadon is supplied for oral use in two main forms. These are a film-coated tablet, which typically comes in 10 mg strength, and an oral suspension (liquid form). The availability of both forms is intended to provide options for administration.


Q: What are the most common reasons why a person might be told they cannot use Lexadon?

A: Regulatory documents list several contraindications, which are reasons the drug must not be used. These commonly include a known hypersensitivity (allergy) to the drug, pre-existing moderate or severe hepatic (liver) impairment, and certain existing heart conditions. It is also restricted in cases where stimulating gut motility might cause harm, such as gastrointestinal hemorrhage.


Q: Can Lexadon be used by people who have certain liver conditions?

A: Official information indicates that use of Lexadon is strictly prohibited for patients with moderate or severe hepatic (liver) impairment. However, regulatory guidance states that a dosage adjustment is not required for individuals diagnosed with only mild hepatic impairment.


Q: Are there any known interactions between Lexadon and common supplements like vitamins or herbal products?

A: Official patient advisories note that there is generally not enough data to confirm the safety of all complementary or herbal remedies when taken with Domperidone. Due to this, combination use is an area for discussion with a healthcare provider.


Q: What is Lexadon's official use in children or adolescents?

A: Lexadon is officially indicated for the symptomatic treatment of dyspeptic symptoms, nausea, and vomiting in adolescents. This usage is generally restricted to individuals who are 12 years of age or older and weigh 35 kilograms or more.


Q: What is the difference between an allergy to Lexadon and a common side effect?

A: Official safety documents define an allergy, or hypersensitivity, as a rare, severe immune reaction, examples of which include anaphylactic reaction or angioedema. In contrast, a common side effect, such as dry mouth or headache, is a dose-related adverse reaction that is not immune-related and is categorized by frequency.


Q: Is it necessary to avoid grapefruit or grapefruit juice while using Lexadon?

A: Yes, some official patient information advises avoiding grapefruit and grapefruit juice. This is because certain components in grapefruit can alter the level of the medicine in the body, which may affect how Lexadon works.


Q: Are there any specific warnings about Lexadon for people with a history of heart issues?

A: Official warnings state that the drug carries a risk of serious cardiac disorders, including ventricular arrhythmias. It is contraindicated in patients with pre-existing cardiac conditions. The drug information notes that caution is warranted in the presence of any history of heart issues.


Q: Can Lexadon be crushed or split if a person has trouble swallowing pills?

A: Official guidelines do not typically support crushing or splitting the tablet form, particularly if it is film-coated. The drug is available as an oral suspension (liquid) that is a licensed alternative form for individuals who experience difficulty swallowing pills.


Q: Is Lexadon considered a 'maintenance' medicine?

A: Official guidelines emphasize that treatment should be limited to the shortest possible duration. The maximum recommendation for acute symptoms like nausea and vomiting is often one week, which suggests the medicine is typically intended for short-term, acute use rather than long-term 'maintenance'.


Q: Do older adults typically use a lower amount of Lexadon?

A: Official documents advise that caution should be exercised when the medicine is administered to older adults due to increased potential risks. While a different standard dose amount is not specified, regulatory advice is to use the lowest effective dose.


Q: Are there any specific lifestyle changes mentioned in official documents when using Lexadon?

A: The official documents explicitly address the use of alcohol. It advises that the co-administration of Lexadon with alcohol should be carefully managed or avoided because of the potential for additive effects resulting in central nervous system depression.


Q: Is it true that Lexadon can affect sleep patterns?

A: Official safety documents list drowsiness as an uncommon side effect. Additionally, other effects on the nervous system, such as anxiety, are listed as uncommon, which are changes that may indirectly impact a person’s overall sleep patterns.


Q: What does it mean if an official document classifies Lexadon as a 'controlled substance'?

A: In major jurisdictions like the United States, Lexadon (Domperidone) is generally not classified as a controlled substance. This classification is typically reserved for medications with a high potential for abuse or dependence.


Q: Is there a known 'washout period' or time for Lexadon to fully leave the system?

A: Pharmacokinetic properties described in regulatory documents indicate that the elimination half-life of Domperidone is approximately mathbf7.0 hours. The half-life refers to the time it takes for the amount of medicine in the body to be reduced by half.


Q: Is the purpose of Lexadon the same for both men and women?

A: Yes, the general purpose of Lexadon is defined by its action as an antiemetic (anti-nausea) and prokinetic agent (gut movement enhancer). This pharmacological description applies to all approved adult users regardless of biological sex.


Q: Does research indicate that Lexadon affects ability to drive or operate machinery?

A: Due to the potential for side effects such as dizziness and drowsiness, patient warnings are often associated with the medication. Warnings often advise against driving or operating complex machinery until the effects of the medicine are known.


Q: Why might a patient need to have blood tests while using Lexadon?

A: Official guidelines note that patients with severe renal (kidney) impairment must be reviewed regularly, and this review often involves blood tests to monitor kidney function. Blood tests may also be used to monitor for electrolyte disturbances, which is relevant given the cardiac risk associated with the drug.


Q: What is the typical age range of participants in the studies for Lexadon?

A: The typical age range for participants in clinical trials investigating conditions like gastrointestinal motility disorders often includes patients who are 16 years of age and older. This demographic covers adolescents, adults, and older adults.


Q: Is Lexadon typically used short-term or long-term?

A: Official regulatory guidelines recommend use for the shortest possible duration. This is evidenced by the maximum recommendation of one week for the acute symptoms of nausea and vomiting, indicating its intended use is typically short-term.


Q: Why are people sometimes concerned about stopping the use of Lexadon?

A: Some reports, mainly from non-official sources, suggest that sudden cessation, particularly after extended periods of use, may result in temporary symptoms. Non-official reports sometimes suggest that gradual dose reduction is noted to help minimize these temporary symptoms.


Q: What regulatory body approved Lexadon for use?

A: Lexadon is approved for use by official government regulatory bodies worldwide. Examples include the European Medicines Agency (EMA) and Health Canada in their respective jurisdictions.


Q: What are the main goals that research evidence aims to measure when studying Lexadon?

A: Research goals commonly aim to measure changes in patient symptoms, such as fatigue and pain scores. Additionally, studies focus on the medicine's effect on physiological actions, particularly the rate of gastric emptying.


Q: How do the side effects of Lexadon change as a person continues to use the medicine?

A: Official safety information notes that most side effects will gradually disappear with continuing administration of the medicine. This suggests that the body often adjusts to the medicine over time.


Q: Why is Lexadon sometimes prescribed for conditions not listed in its primary purpose?

A: Research has been conducted to explore the association of the medicine with potential changes in symptoms of other conditions. Examples from studies include Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM), which may lead to clinical interest in its use for these areas.


Q: What is the difference between Lexadon tablets and capsules?

A: Lexadon is officially provided as a tablet and an oral suspension (liquid). In some regions, other forms may be available through compounding pharmacies. The drug is typically not supplied as an official, commercial capsule product.


Q: Do clinical trials mention any impact of Lexadon on appetite or body weight?

A: Clinical studies have been conducted specifically to investigate the effect of the medicine on the gastric emptying rate. Some of these studies also examine subjective appetite sensations.


Q: What are the high-level themes of the major research studies conducted on Lexadon?

A: Major research evidence themes include the evaluation of its use in Chronic Fatigue Syndrome (CFS), assessing effects on post-exertional malaise, and its potential applications in Fibromyalgia (FM), examining changes in generalized pain scores.


Q: How is the safety profile of Lexadon monitored after it is approved?

A: Post-approval safety is monitored through formal government programs. These programs, such as the Canada Vigilance Program, actively collect reports of suspected adverse reactions for health products once they are available for use.


Q: Can people who have kidney issues still use Lexadon?

A: Yes, individuals with severe renal (kidney) impairment can still use Lexadon. Official documents state that the dosing frequency must be reduced in these cases.


Q: Do official documents mention any effects of Lexadon on mood or behavior?

A: Official safety documents list uncommon side effects that are categorized under Nervous/Psychiatric disorders. These include effects such as anxiety and irritability, which are changes that may affect mood or behavior.

How should Lexadon be stored and disposed of?

Lexadon (Domperidone) must be stored and disposed of based strictly on official regulatory labeling to ensure its quality and prevent harm.

Item Requirement
Storage Temperature Store at controlled room temperature, typically 15, C to 30, C. Do not store above 30, C.
Protection Keep the medicine protected from light and moisture in a dry place. The product must not be frozen or refrigerated.
Container Rule Store only in the original container, which must be kept tightly closed.
Child Safety The medicine must be stored out of the sight and reach of children.
Disposal Rule Do not dispose of Lexadon via wastewater or household waste. Unused or expired product must be discarded according to local regulatory requirements for pharmaceutical waste, often through official take-back schemes.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lexadon found in:

A-Z Index: